›› 2009, Vol. 29 ›› Issue (7): 886-.

• Review • Previous Articles     Next Articles

Research progress in inhibition of corneal neovascularization by anti-VEGF therapy

WANG Jia-yin, reviewer;KE Bi-lian, reviser   

  1. Department of Ophthalmology, The First People's Hospital, Shanghai Jiaotong University, Shanghai 200080, China
  • Online:2009-07-25 Published:2009-09-16

Abstract:

Corneal neovascularization is a significant and sightthreatening complication of many ocular surface disorders, and may cause corneal scar and rejection reaction after corneal grafting. Recent studies have revealed that vascular endothelial growth factor (VEGF) plays an important role in corneal neovascularization, and inhibition of VEGF has become a main strategy for treatment of corneal neovascularization. This article reviews the research progress in inhibition of corneal neovascularization by antiVEGF therapy.

Key words: corneal neovascularization, vascular endothelial growth factor, treatment